A revised model for invariant chain-mediated assembly of MHC class II peptide receptors

Trends in Biochemical Sciences

Volumn 32, Issue 12, 2007, Pages 532-537

  Koch, Norbert ^a   McLellan, Alexander D ^b   Neumann, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OLIGOMER; PROTEIN SUBUNIT;

ALLELE; ALPHA CHAIN; AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ARTICLE; BETA CHAIN; BINDING SITE; CD4+ T LYMPHOCYTE; COMPLEX FORMATION; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN GENOME; IMMUNE SYSTEM; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SINGLE NUCLEOTIDE POLYMORPHISM;

BINDING SITES; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; MODELS, MOLECULAR; PROTEIN BINDING; RECEPTORS, PEPTIDE;

EID: 36249013613     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2007.09.007     Document Type: Article

References (41)

1. The International SNP Map Working Group (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933
2. Wubbolts R., and Neefjes J. Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperone and motors. Immunol. Rev. 172 (1999) 189-208
3. Germain R.N. Binding domain regulation of MHC class II molecule assembly, trafficking, fate and function. Semin. Immunol. 7 (1995) 361-372
4. Trowsdale J. HLA genomics in the third millenium. Curr. Opin. Immunol. 17 (2005) 498-504
5. Cresswell P. Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 12 (1994) 259-293
6. Malissen B., et al. Cotransfer of the Eαd and Aßd genes into L cells results in the surface expression of a functional mixed-isotype Ia molecules. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 3958-3962
7. Bikoff E.K., et al. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2 (1995) 301-310
8. Layet C., and Germain R.N. Invariant chain promotes egress of poorly expressed, haplotype mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2346-2350
9. Elliott E.A., et al. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179 (1994) 681-694
10. Marks M.S., et al. Transient aggregation of major histocompatibility complex class II chains during assembly in normal spleen cells. J. Biol. Chem. 270 (1995) 10475-10481
11. Bonnerot C., et al. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J. 13 (1994) 934-944
12. Anderson K.S., and Cresswell P. A role of calnexin (IP90) in the assembly of class II MHC molecules. EMBO J. 13 (1994) 675-682
13. Schaiff W.T., et al. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp. Med. 176 (1992) 657-666
14. Anderson M.S., and Miller J. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2282-2286
15. Denzin L.K., and Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82 (1995) 155-165
16. Bijlmakers M.J., et al. Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J. 13 (1994) 2699-2707
17. Lamb C.A., and Cresswell P. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148 (1992) 3478-3482
18. Kvist S., et al. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29 (1982) 61-69
19. Lotteau V., et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348 (1990) 600-605
20. Teyton L., et al. Invariant chain distinguishes between exogenous and endogenous antigen presentation pathways. Nature 348 (1990) 39-44
21. Nadimi F., et al. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur. J. Immunol. 21 (1991) 1255-1263
22. Koonce C.H., and Bikoff E.K. Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice. J. Immunol. 173 (2004) 3271-3280
23. Neumann J., et al. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain. Int. Immunol. 19 (2006) 31-39
24. Busch R., et al. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15 (1996) 418-428
25. Hitzel C., et al. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain. J. Immunol. 154 (1995) 1048-1056
26. Sanderson F., et al. Association between HLA-DM and HLA-DR in vivo. Immunity 4 (1996) 87-96
27. Kang S.J., and Cresswell P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J. 21 (2002) 1650-1660
28. Marks M.S., et al. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111 (1990) 839-855
29. Newcomb J.R., et al. Trimeric interactions of the invariant chain and its association with major histocompatibility complex class II αβ dimers. J. Biol. Chem. 271 (1996) 24249-24256
30. Dixon A.M., et al. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly. Biochemistry 45 (2006) 5228-5234
31. Castellino F., et al. The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 31 (2001) 841-850
32. Wilson N.A., et al. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J. Immunol. 161 (1998) 4777-4784
33. Ghosh P., et al. The structure of an intermediate in class II MHC maturation. Nature 378 (1995) 457-462
34. Neumann J., and Koch N. Assembly of major histocompatibility complex class II subunits with invariant chain. FEBS Lett. 579 (2005) 6055-6059
35. Neumann J., and Koch N. A novel domain on HLA-DRβ chain regulates the chaperone role of invariant chain. J. Cell Sci. 119 (2006) 4207-4212
36. Narayan K., et al. HLA-DM targets the hydrogen bond between the histidine β81 and peptide to dissociate HLA-DR-peptide complexes. Nat. Immunol. 8 (2007) 92-100
37. Verreck F.A., et al. Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM. Eur. J. Immunol. 31 (2001) 1029-1036
38. Cresswell P. Invariant chain structure and MHC class II function. Cell 84 (1996) 505-507
39. Sant A.J., et al. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex α/β chains. J. Exp. Med. 174 (1991) 799-808
40. Sung E., and Jones P.P. The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localisation. Mol. Immunol. 18 (1981) 899-913
41. Graf L., et al. Expression of Ia antigens in a murine T-lymphoma variant. Mol. Immunol. 22 (1985) 1371-1377